Exhibit 10.45


 


THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN
REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR FOREIGN JURISDICTION, AND MAY BE
OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF U.S. FEDERAL AND STATE OR APPLICABLE FOREIGN
SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER
U.S. FEDERAL AND STATE OR APPLICABLE FOREIGN SECURITIES LAWS IS NOT REQUIRED.


 


Bonne
SantÉ Group, INC.


2020 STOCK INCENTIVE PLAN




NOTICE OF RESTRICTED STOCK AWARD


 


Bonne Santé Group, Inc. (the “Company”)
hereby grants to the Grantee named below the following restricted stock award to purchase shares of its common stock (“Shares”).
The terms and conditions of this award are set forth in the Restricted Stock Award Agreement and the Bonne Santé Group, Inc. 2020
Stock Incentive Plan (the “Plan”), both of which are attached to and made a part of this document.


 


	
    Date of Grant:
	 
	 	 
	Name of Grantee:	 
	 	 
	Number of Shares:	 
	 	 
	Purchase Price per Share:	 
	 	 
	Vesting Start Date:	 
	 	 
	Vesting Schedule:	 


 




     


     


    

 


Bonne
Santé Group, Inc.

2020 Stock Incentive Plan






RESTRICTED
STOCK AWARD AGREEMENT


 


1. Restricted
Stock Award and Transfer. Upon execution of this Agreement, the Company shall issue to the Grantee the number of shares of
restricted Common Stock of the Company, $0.0001 par value per share, as is set forth in the Notice of Restricted Stock Award (the “Stock”),
at a purchase price as specified in the Notice of Restricted Stock Award, subject to the restrictions and other terms set forth herein
(the “Award”).


 


2. Adjustments
to Stock. In the event of a stock split, a stock dividend or a similar change in the Company’s Stock, the number of shares
of Stock covered by this Award and the Purchase Price Per Share (as defined in the Notice of Restricted Stock Award) may be adjusted pursuant
to the Plan. Grantee’s Award shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event
the Company is subject to such corporate activity as set forth in the Plan.


 


3. Right
of Repurchase.


 


(a) The
Company shall have the right to repurchase all or any part of the shares of Stock (whether or not vested) received pursuant to this Award
(a “Repurchase Right”) on the terms and conditions below. The Company’s Repurchase Right shall be exercisable
only within the ninety (90) day period following a Repurchase Event, or such longer period as may be required to avoid a charge to earnings
for financial accounting purposes or as otherwise agreed to by the Company and the Grantee (the “Repurchase Period”).
Each of the following events shall constitute a “Repurchase Event:”


 


(i) Termination
of Grantee’s continuous Service for any reason or no reason, with or without cause, including death or Disability, in which event
the Repurchase Period shall commence on the date of termination of Grantee’s continuous Service.


 


(ii) Grantee,
Grantee’s legal representative, or other holder of shares acquired pursuant to this Restricted Stock Award Agreement attempts to
sell, exchange, transfer, pledge, or otherwise dispose of any of the Stock in violation of this Agreement or the Right of First Refusal
(as defined below), in which event the Repurchase Period shall commence on the date the Company receives actual notice of such attempted
sale, exchange, transfer, pledge or other disposition.


 


(iii) The
receivership, bankruptcy, or other creditor’s proceeding regarding Grantee or the taking of any of the Stock by legal process, such
as a levy of execution, in which event the Repurchase Period shall commence on the date the Company receives actual notice of the commencement
of pendency of the receivership, bankruptcy or other creditor’s proceeding or the date of such taking, as the case may be, and the
Fair Market Value of the shares shall be determined as of the last day of the month preceding the month in which the proceeding involved
commenced or the taking occurred.


 


(b) The
Company may exercise the Repurchase Right for all or any portion of the Grantee’s Stock in the Company’s sole discretion and
may choose to exercise the Repurchase Right to acquire only the unvested portion of Grantee’s Stock if the Company so desires. The
Company shall exercise its Repurchase Right only for cash for the Stock and shall give Grantee written notice (accompanied by payment
for the Stock) within ninety (90) calendar days after the later of the Repurchase Event or a proper purchase of the Stock following such
Repurchase Event (including after any extension of the Repurchase Period to avoid a charge to earnings for financial accounting purposes).


 






    2


     


    

 


(c) The
repurchase price for vested shares shall be equal to the shares’ Fair Market Value at the time of the Repurchase Event. The Company
may repurchase unvested shares at a price equal to the original price per share that Grantee paid pursuant to Section 1 above.


 


4. Limitations
on Transfer; The Company’s Right of First Refusal. In addition to any other limitation on transfer created by applicable
securities laws or the Company’s certificate of incorporation or bylaws, before any shares of Stock registered in the name of Grantee
may be sold or transferred, such shares shall first be offered to the Company as follows (the “Right of First Refusal”):


 


(a) Grantee
shall promptly deliver a notice (“Notice”) to the Company stating (i) Grantee’s bona fide intention to sell
or transfer such shares of Stock, (ii) the number of such shares to be sold or transferred, and the basic terms and conditions of
such sale or transfer, (iii) the price for which Grantee proposes to sell or transfer such shares of Stock, (iv) the name of
the proposed purchaser or transferee, and (v) proof satisfactory to the Company that the proposed sale or transfer will not violate
any applicable U.S. federal, state or foreign securities laws. The Notice shall be signed by both Grantee and the proposed purchaser or
transferee and must constitute a binding commitment subject to the Right of First Refusal as set forth herein.


 


(b) Within
thirty (30) days after receipt of the Notice, the Company may elect to purchase all or any portion of the shares to which the Notice refers,
at the price per share specified in the Notice. If the Company elects not to purchase all or any portion of the shares, the Company may
assign its right to purchase all or any portion of the shares. The assignees may elect within thirty (30) days after receipt by the Company
of the Notice to purchase all or any portion of the shares to which the Notice refers, at the price per share specified in the Notice.
An election to purchase shall be made by written notice to Grantee. Payment for shares purchased pursuant to this Section 4 shall
be made within thirty (30) days after receipt of the Notice by the Company and, at the option of the Company, may be made by cancellation
of all or a portion of outstanding indebtedness, if any, or in cash or both.


 


(c) If
all or any portion of the shares to which the Notice refers are not elected to be purchased, as provided in Section 4(b), Grantee may
sell those shares to any person named in the Notice at the price specified in the Notice, provided that such sale or transfer is consummated
within sixty (60) days of the date of said Notice to the Company, and provided, further, that any such sale is made in compliance with
applicable U.S. federal, state and foreign securities laws and not in violation of any other contractual restrictions to which Grantee
is bound. The third-party purchaser shall be bound by, and shall acquire the shares of stock subject to, the provisions of this Agreement,
including the Right of First Refusal.


 


(d) Any
proposed transfer on terms and conditions different from those set forth in the Notice, as well as any subsequent proposed transfer shall
again be subject to the Right of First Refusal and shall require compliance with the procedures described in this Section 4.


 


(e) Grantee
agrees to cooperate affirmatively with the Company, to the extent reasonably requested by the Company, to enforce rights and obligations
pursuant to this Agreement.


 


(f) Notwithstanding
the above, neither the Company nor any assignee of the Company under this Section 4 shall have any right under this Section 4
at any time subsequent to the closing of a public offering of the common stock of the Company pursuant to a registration statement declared
effective under the U.S. Securities Act of 1933, as amended (the “Securities Act”).


 


(g) This
Section 4 shall not apply to (i) a transfer by will or intestate succession, or (ii) a transfer to one or more members
of Grantee’s Immediate Family (defined below) or to a trust established by Grantee for the benefit of Grantee and/or one or more
members of Grantee’s Immediate Family, provided that the transferee agrees in writing on a form prescribed by the Company to be
bound by all of the provisions of this Agreement to the same extent as they apply to Grantee. The transferee shall execute a copy of the
attached Annex I and file the same with the Secretary of the Company. For purposes of this Agreement, “Immediate Family”
means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law,
brother-in-law or sister-in-law, and shall include adoptive relationships.


 






    3


     


    

 


5. Rights
of Grantee. Subject to the provisions of Sections 4, 5, 9 and 10 herein, Grantee shall exercise all rights and privileges
of a stockholder of the Company with respect to the Stock. Grantee shall be deemed to be the holder for purposes of receiving any dividends
that may be paid with respect to such shares of Stock and for the purpose of exercising any voting rights relating to such shares of Stock,
even if some or all of such shares of Stock have not yet vested and been released from the Repurchase Right.


 


6. Restrictive
Legends. All certificates representing the Stock shall have endorsed thereon legends in substantially the following forms (in
addition to any other legend which may be required by other agreements between the parties hereto):


 


(a) THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR
THE SECURITIES LAWS OF ANY STATE OR FOREIGN JURISDICTION, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE
RELEVANT PROVISIONS OF U.S. FEDERAL AND STATE OR APPLICABLE FOREIGN SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL
SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER U.S. FEDERAL AND STATE OR APPLICABLE FOREIGN SECURITIES LAWS IS
NOT REQUIRED.


 


(b) THE
SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE
WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE COMPANY AND THE INITIAL HOLDER HEREOF. SUCH AGREEMENT PROVIDES FOR CERTAIN TRANSFER
RESTRICTIONS, INCLUDING A REPURCHASE RIGHT AND RIGHTS OF FIRST REFUSAL UPON AN ATTEMPTED TRANSFER OF THE SECURITIES. THE SECRETARY OF
THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.


 


7. Investment
Representations. In connection with the purchase of the Stock, Grantee represents to the Company the following:


 


(a) Grantee
is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the Company to
reach an informed and knowledgeable decision to acquire the Stock. Grantee is purchasing the Stock for investment for Grantee’s
own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of
the Securities Act.


 


(b) Grantee
understands that the Stock has not been registered under the Securities Act by reason of a specific exemption therefrom, which exemption
depends upon, among other things, the bona fide nature of Grantee’s investment intent as expressed herein.


 


(c) Grantee
further acknowledges and understands that the Stock must be held indefinitely unless the Stock is subsequently registered under the Securities
Act or an exemption from such registration is available. Grantee further acknowledges and understands that the Company is under no obligation
to register the Stock. Grantee understands that the certificate evidencing the Stock will be imprinted with a legend, which prohibits
the transfer of the Stock unless the Stock is registered, or such registration is not required in the opinion of counsel for the Company.


 






    4


     


    

 


(d) Grantee
is familiar with the provisions of Rule 144 and Rule 701, under the Securities Act, as in effect from time to time, which, in substance,
permit limited public resale of “restricted securities” (as defined in the Securities Act) acquired, directly or indirectly,
from the issuer thereof (or from an affiliate of such issuer), in a non-public offering subject to the satisfaction of certain conditions.
Rule 701 provides that if the issuer qualifies under Rule 701 at the time of issuance of the securities, such issuance will be exempt
from registration under the Securities Act. In the event the Company becomes subject to the reporting requirements of Section 13
or 15(d) of the Securities Exchange Act of 1934, as amended, the securities exempt under Rule 701 may be sold by Grantee ninety (90)
days thereafter, subject to the satisfaction of certain of the conditions specified by Rule 144 and the market stand-off provision
described in Section 8 below. In the event that the sale of the Stock does not qualify under Rule 701 at the time of purchase, then
the Stock may be resold by Grantee in certain limited circumstances subject to the provisions of Rule 144, which require, among other
things: (i) the availability of certain public information about the Company; and (ii) the resale occurring following the required holding
period under Rule 144 after Grantee has purchased, and made full payment of (within the meaning of Rule 144), the securities to be sold.


 


(e) Grantee
further understands that at the time Grantee wishes to sell the Stock there may be no public market upon which to make such a sale, and
that, even if such a public market then exists, the Company may not be satisfying the current public information requirements of Rule
144 or Rule 701, and that, in such event, Grantee would be precluded from selling the Stock under Rule 144 or Rule 701 even if the minimum
holding period requirement had been satisfied.


 


(f) Grantee
further warrants and represents that Grantee has either (i) preexisting personal or business relationships with the Company or any
of its officers, directors or controlling persons, or (ii) the capacity to protect his own interests in connection with the purchase of
the Stock by virtue of the business or financial expertise of himself or of professional advisors to Grantee who are unaffiliated with
and who are not compensated by the Company or any of its affiliates, directly or indirectly.


 


8. Market
Stand-Off Agreement.  Grantee hereby agrees that in connection with any underwritten public offering by the Company of its
equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial
public offering, Grantee shall not, directly or indirectly, engage in any transaction prohibited by the underwriter, or sell, make any
short sale of, contract to sell, transfer the economic risk of ownership in, loan, hypothecate, pledge, grant any option for the purchase
of, or otherwise dispose or transfer for value or agree to engage in any of the foregoing transactions with respect to any Common Stock
without the prior written consent of the Company or its underwriters, for such period of time after the effective date of such registration
statement as may be requested by the Company or such underwriters. Such period of time shall not exceed one hundred eighty (180) days
and may be required by the underwriter as a market condition of the offering; provided, however, that if either (a) during the last seventeen
(17) days of such one hundred eighty (180) day period, the Company issues an earnings release or material news or a material event relating
to the Company occurs or (b) prior to the expiration of such one hundred eighty (180) day period, the Company announces that it will release
earnings results during the sixteen (16) day period beginning on the last day of the one hundred eighty (180) day period, then the restrictions
imposed during such one hundred eighty (180) day period shall continue to apply until the expiration of the eighteen (18) day period beginning
on the issuance of the earnings release or the occurrence of the material news or material event; provided, further, that in the event
the Company or the underwriter requests that the one hundred eighty (180) day period be extended or modified pursuant to then-applicable
law, rules, regulations or trading policies, the restrictions imposed during the one hundred eighty (180) day period shall continue to
apply to the extent requested by the Company or the underwriter to comply with such law, rules, regulations or trading policies. Grantee
hereby agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter which are
consistent with the foregoing or which are necessary to give further effect thereto. To enforce the provisions of this Section, the Company
may impose stop-transfer instructions with respect to the Common Stock until the end of the applicable stand-off period.


 






    5


     


    

 


9. Section
83(b) Election. Grantee understands that Section 83(a) of the Internal Revenue
Code of 1986, as amended (the “Code”), taxes as ordinary income the difference between the amount paid for the Stock
and the fair market value of the Stock as of the date any restrictions on the Stock lapse. In this context, “restriction”
includes the right of the Company to buy back the Stock pursuant to the Repurchase Right set forth in Section 3 above. Grantee understands
that Grantee may elect to be taxed at the time the Stock is purchased, rather than when and as the Repurchase Right expires, by filing
an election under Section 83(b) (an “83(b) Election”) of the Code with the Internal Revenue Service within thirty (30)
days from the date of purchase. Even if the fair market value of the Stock at the time of the execution of this Agreement equals the amount
paid for the Stock, the 83(b) Election must be made to avoid income under Section 83(a) in the future. Grantee understands that failure
to file such an 83(b) Election in a timely manner may result in adverse tax consequences for Grantee. Grantee further understands that
an additional copy of such 83(b) Election is required to be filed with his or her federal income tax return for the calendar year in which
the date of this Agreement falls. Grantee acknowledges that the foregoing is only a summary of the effect of United States federal income
taxation with respect to the purchase of the Stock hereunder, and does not purport to be complete. Grantee further acknowledges that the
Company has directed Grantee to seek independent advice regarding the applicable provisions of the Code, the income tax laws of any municipality,
state or foreign country in which Grantee may reside, and the tax consequences of Grantee’s death. Grantee assumes all responsibility
for filing an 83(b) Election and paying all taxes resulting from such election or the lapse of the restrictions on the Stock. Grantee
agrees that Grantee is responsible for consulting Grantee’s own tax advisor as to the tax consequences associated with Grantee’s
Stock. The tax rules governing this Award are complex, change frequently and depend on the individual taxpayer’s situation.


 


10. Refusal
to Transfer. The Company shall not be required (a) to transfer on its books any shares of Stock of the Company which shall
have been transferred in violation of any of the provisions set forth in this Agreement or the Right of First Refusal or (b) to treat
as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares shall have
been so transferred.


 


11. No
Employment Rights. This Agreement is not an employment contract and nothing in this Agreement shall affect in any manner whatsoever
the right or power of the Company (or a parent or Subsidiary of the Company) to terminate Grantee’s employment for any reason at
any time, with or without Cause and with or without notice.


 


12. Other
Necessary Actions. The parties agree to execute such further instruments and to take such further action as may reasonably
be necessary to carry out the intent of this Agreement.


 


13. Notice.
Any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given upon
the earliest of personal delivery, receipt or the third full day following deposit in the United States Post Office with postage and fees
prepaid, addressed to the other party hereto at the address last known or at such other address as such party may designate by ten (10)
days’ advance written notice to the other party hereto.


 






    6


     


    

 


14. Successors
and Assigns. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions
on transfer herein set forth, be binding upon Grantee and Grantee’s heirs, executors, administrators, successors and assigns. The
failure of the Company in any instance to exercise the Right of First Refusal described herein shall not constitute a waiver of any other
Right of First Refusal that may subsequently arise under the provisions of this Agreement. No waiver of any breach or condition of this
Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of a like or different nature.


 


15. Applicable
Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, as such laws
are applied to contracts entered into and performed in such state.


 


16. No
State Qualification. THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH ANY STATE
SECURITIES LAW ADMINISTRATOR, AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR
PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION. THE RIGHTS OF ALL PARTIES TO THIS
AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.


 


17. No
Oral Modification. No modification of this Agreement shall be valid unless made in writing and signed by the parties hereto.


 


18. Entire
Agreement. This Agreement and the Plan constitute the entire complete and final agreement between the parties hereto with regard
to the subject matter hereof.


 


19. The
Plan And Other Agreements. The text of the Plan is incorporated in this Agreement by reference. Certain capitalized terms used
in this Agreement are defined in the Plan. The Notice of Restricted Stock Award, this Agreement, including its attachments, and the Plan
constitute the entire understanding between Grantee and the Company regarding this Award. Any prior agreements, commitments or negotiations
concerning this Award are superseded. By signing this Agreement, Grantee acknowledges receipt of a copy of the Plan, and agrees that (a)
Grantee has carefully read, fully understands and agrees to all of the terms and conditions described in this Agreement and the Plan;
and (b) Grantee has been given an opportunity to consult Grantee’s own legal and tax counsel with respect to all matters relating
to this restricted stock award prior to signing this Agreement and that Grantee has either consulted such counsel or voluntarily declined
to consult such counsel.


 


20. Attorneys’
Fees; Specific Performance. Grantee shall reimburse the Company for all costs incurred by the Company in enforcing the performance
of, or protecting its rights under, any part of this Agreement, including reasonable costs of investigation and attorneys’ fees.
It is the intention of the parties that the Company, upon exercise of the Repurchase Right or Right of First Refusal and payment of the
applicable consideration for the Stock, pursuant to the terms of this Agreement, shall be entitled to receive the Stock, in specie, in
order to have such Stock available for future issuance without dilution of the holdings of other stockholders. Furthermore, it is expressly
agreed between the parties that money damages are inadequate to compensate the Company for the Stock and that the Company shall, upon
proper exercise of the Repurchase Right or Right of First Refusal, be entitled to specific enforcement of its rights to purchase and receive
the Stock.


 






    7


     


    

 


21. Miscellaneous
Provisions.


 


(a) Grantee
understands and acknowledges that (i) the Plan is entirely discretionary, (ii) the Company and Grantee’s employer have
reserved the right to amend, suspend or terminate the Plan at any time, (iii) the Award does not in any way create any contractual
or other right to receive additional awards at any time or in any amount and (iv) all determinations with respect to any additional
awards, including (without limitation) the times when awards will be granted, the number of shares of stock offered, the exercise price
or purchase price, as applicable, and the vesting schedule, will be at the sole discretion of the Company.


 


(b) Grantee
understands and acknowledges that participation in the Plan ceases upon termination of Grantee’s Service for any reason, except
as may explicitly be provided otherwise in the Plan or this Agreement.


 


(c) Grantee
hereby authorize and directs its employer to disclose to the Company or any Subsidiary any information regarding Grantee’s employment,
the nature and amount of Grantee’s compensation and the fact and conditions of Grantee’s participation in the Plan, as Grantee’s
employer deems necessary or appropriate to facilitate the administration of the Plan.


 


(d) Grantee
consents to the collection, use and transfer of personal data as described in this Subsection. Grantee understands and acknowledges that
the Company, Grantee’s employer and the Company’s other Subsidiaries hold certain personal information regarding Grantee for
the purpose of managing and administering the Plan, including (without limitation) Grantee’s name, home address, telephone number,
date of birth, social insurance number, salary, nationality, job title, any Stock or directorships held in the Company and details of
all options or any other entitlements to Stock awarded, canceled, exercised, vested, unvested or outstanding in Grantee’s favor
(the “Data”). Grantee further understand and acknowledge that the Company and/or its Subsidiaries will transfer Data
among themselves as necessary for the purpose of implementation, administration and management of Grantee’s participation in the
Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation,
administration and management of the Plan. Grantee understands and acknowledges that the recipients of Data may be located in the United
States or elsewhere. Grantee authorizes such recipients to receive, possess, use, retain and transfer Data, in electronic or other form,
for the purpose of administering Grantee’s participation in the Plan, including a transfer to any broker or other third party with
whom Grantee elect to deposit shares of Stock acquired under the Plan of such Data as may be required for the administration of the Plan
and/or the subsequent holding of Stock on Grantee’s behalf. Grantee may, at any time, view the Data, require any necessary modifications
of Data or withdraw the consents set forth in this Subsection by contacting the Human Resources Department of the Company or its equivalent
in writing.


 


(e) If
one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision
in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i)
such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if such provision were
so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms.


 


(f) This
Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall constitute
one instrument.


 


[SIGNATURE PAGE FOLLOWS]


 




    8


     


    

 


In
Witness Whereof, the parties hereto have executed this Agreement as of the day and year first above written.


 


	 	Bonne Santé Group, Inc.
	 	 
	 	By:	                    
	 	Name:  	 
	 	Title:	 



 


	 	Address: 	   
	 	 	 
	 	 	 
	 	 
	 	GRANTEE:
	 	 
	 	 
	 	(Signature)
	 	 
	 	 
	 	Name (Please Print)
	 	 
	 	Address:	 
	 	 	 
	 	 	 



 


Bonne Sante
Group, Inc.

Restricted Stock Award Agreement


 




     


     


    

 


ANNEX I


 


ACKNOWLEDGMENT OF AND AGREEMENT TO BE BOUND

BY THE RESTRICTED STOCK AWARD AGREEMENT OF

bonne Santé Group, Inc.


 


The undersigned, as transferee of shares of Bonne
Santé Group, Inc. hereby acknowledges that he or she has read and reviewed the terms of the Restricted Stock Award Agreement of
Bonne Santé Group, Inc. and hereby agrees to be bound by the terms and conditions thereof, as if the undersigned had executed said
Agreement as an original party thereto.


 


Dated: ____________________, ____.





 


	 	 
	 	(Signature of Transferee)
	 	 
	 	 
	 	(Printed Name of Transferee)